Male sex determination hinges on the development of testes in the embryo, beginning with the differentiation of Sertoli cells under the influence of the Y-linked gene SRY. Sertoli cells then orchestrate fetal testis formation including the specification of fetal Leydig cells (FLCs) that produce steroid hormones to direct virilization of the XY embryo. As the majority of XY disorders of sex development (DSDs) remain unexplained at the molecular genetic level, we reasoned that genes involved in FLC development might represent an unappreciated source of candidate XY DSD genes. To identify these genes, and to gain a more detailed understanding of the regulatory networks underpinning the specification and differentiation of the FLC population, we developed methods for isolating fetal Sertoli, Leydig, and interstitial cell-enriched subpopulations using an Sf1-eGFP transgenic mouse line. RNA sequencing followed by rigorous bioinformatic filtering identified 84 genes upregulated in FLCs, 704 genes upregulated in nonsteroidogenic interstitial cells, and 1217 genes upregulated in the Sertoli cells at 12.5 days postcoitum. The analysis revealed a trend for expression of components of neuroactive ligand interactions in FLCs and Sertoli cells and identified factors potentially involved in signaling between the Sertoli cells, FLCs, and interstitial cells. We identified 61 genes that were not known previously to be involved in specification or differentiation of FLCs. This dataset provides a platform for exploring the biology of FLCs and understanding the role of these cells in testicular development. In addition, it provides a basis for targeted studies designed to identify causes of idiopathic XY DSD.
INTRODUCTION
The morphogenesis of the testes involves the coordinated differentiation of a number of bipotential cell lineages in the gonadal primordium into testis-specific cell types (for review, see [1] ). This process begins with the expression of the Ylinked gene Sry (sex determining region of Chr Y), which directs differentiation of Sertoli cells that assemble into cords encapsulating the germ cells. Sertoli cells then influence the differentiation of other cell types within the testes, including the fetal Leydig cells (FLCs), which arise in the interstitium and act as factories for the production of steroid hormones (androgens) that play a major role in masculinization of the XY individual. Other cell types also arise in the testicular interstitium, the nature and function(s) of which are mostly unclear. Some interstitial cells that do not differentiate as FLCs are thought to give rise to adult Leydig cells (ALCs), which maintain androgen production throughout life [2] . The differentiation, function, and interaction of the various cellular subcompartments of the developing testis need to be carefully orchestrated in a spatiotemporal manner, but how this regulation is achieved remains poorly understood.
Disorders of sex development (DSDs) are congenital birth defects characterized by development of atypical chromosomal, gonadal, or anatomical sex. Although the term DSD includes a wide spectrum of conditions, loss or compromised function of genes directing gonadal development during fetal life is a common cause (for review see [3] ). As many of the known genes at fault in XY DSD are those regulating gonadogenesis, we hypothesized that defects in specification and differentiation of FLCs or nonsteroidogenic interstitial cells (NSICs) may underlie some classes of human DSD. Currently, few genes and encoded factors are known to direct FLC fate determination and differentiation [4] , and even less is known regarding how ALC progenitors are specified from interstitial cells during fetal life [2] . Hedgehog signaling is evidently a positive regulator of FLC differentiation, given that Dhh À/À (Desert hedgehog) XY gonads have reduced FLC numbers [5] [6] [7] , and that constitutively active hedgehog signaling in the ovary is sufficient to induce some interstitial cells to differentiate along the steroidogenic pathway [8] . Similarly, Pdgfra À/À (platelet derived growth factor receptor, apolypeptide) XY gonads show abnormal FLC differentiation [9] . Additionally, the aristaless-related homeobox gene (ARX) plays some role in FLC specification based on the fact that Arx À/À XY mouse gonads have reduced FLC numbers. Interestingly, Arx is not expressed in FLCs, although it may be expressed in their progenitors [10, 11] .
Previous transcriptomic studies aimed at identifying genes important for development of the fetal gonads in mice, or for establishing the molecular signatures of the component cell lineages, have been performed using microarrays [12] [13] [14] [15] [16] . Although this method reveals the expression dynamics of thousands of genes simultaneously, it is limited by the incomplete representation of genes on the array and also by the relatively low sensitivity and dynamic range offered [17] .
Additionally, the non-Sertoli gonadal somatic populations studied in previous microarray screens have included a mixture of FLCs and NSICs because of an inability to separate these two populations. Hence, using available microarray datasets, it has been difficult to address the specific question of how FLCs arise and to determine the molecular characteristics of these cells at 12.5 days postcoitum (dpc), prior to the expression of steroidogenic pathway genes.
In this study, we designed and implemented a strategy to separate mouse fetal gonadal cells into four distinct subpopulations-Sertoli cells, germ cells, FLCs, and heterogeneous NSICs-using a fluorescence-activated cell sorting (FACS)-based protocol in combination with a Sf1-enhanced green fluorescent protein (eGFP) transgenic mouse line [12] . We used massively parallel sequencing (RNA-seq) to carry out differential gene expression analysis and construct a molecular portrait of FLCs at 12.5 dpc, just at the onset of steroidogenesis. The aim of this study was to identify early lineage markers of the FLC and NSIC populations in order to provide insight into the signaling interactions in the early gonad. The output generated by our approach reveals potential markers for presteroidogenic FLCs, suggests likely signaling relationships among Sertoli cells, FLCs, and NSICs, and reveals new candidate genes that may underlie the fetal origins of DSDs.
MATERIALS AND METHODS

Mouse Strains
Embryos were collected from timed matings of Sf1-eGFP (Nr5a1)-strain mice [12] , with noon of the day on which the mating plug was observed, designated 0.5 dpc. All animal protocols were approved by the University of Queensland Animal Ethics Committee.
Immunofluorescence
Section. Embryos were fixed in 4% paraformaldehyde in PBS overnight at 48C, dehydrated, and embedded in paraffin; 7-lm sections were cut using a Leica microtome. Slides were dewaxed by 2 3 10 min washes in xylene, rehydrated, boiled for 5 min in Antigen Unmasking Solution (Vector Laboratories), and incubated in the unmasking solution at room temperature for 60 min. The slides were washed for 3 3 10 min in 0.1% Triton-X in PBS (PBTx) and incubated with primary antibodies diluted in blocking buffer (10% heat-inactivated serum supreme in PBTx) at 48C overnight, followed by washing and reblocking for 30 min at room temperature. Slides were incubated with secondary antibodies in blocking buffer at room temperature for 2 h, washed, and mounted in 60% glycerol/PBS. Sections were imaged by confocal microscopy using a Zeiss LSM-510 META or LSM-710 META confocal microscope. For details of primary and secondary antibodies see Supplemental Tables S1 and S2 (Supplemental Data are available online at www.biolreprod. org).
FACS cells. The protocol was modified from online methods [18] . Briefly, cells were sorted as described below from 12.5-dpc gonad-only samples into ice-cold PBS and kept on ice. A volume of PBS containing between 3000 and 10 000 ''events'' (;200 ll) was plated into an area demarcated on a Tissue Tack slide (24216; Polysciences Inc.) and allowed to adhere for 15 min before being fixed in 4% paraformaldehyde for 15 min at room temperature and washed with PBS. Slides were blocked in permeabilization/blocking buffer (P/B buffer; 1% bovine serum albumin in PBTx) for 30 min at RT and incubated at 48C overnight with the primary antibody diluted in P/B buffer. The slides were washed for 1 3 5 min in P/B buffer and then 3 3 10 min in PBTx and incubated with secondary antibodies diluted in P/B buffer for 1 h at room temperature. Slides were DAPI stained, washed, and mounted in 60% glycerol/ PBS. Fields of cells were imaged by fluorescent microscopy using a Olympus BX-51 microscope and counted in ImageJ using the CellCounter plug-in. For details of primary and secondary antibodies see Supplemental Tables S1 and  S2 .
FACS Sorting of Cell Populations
Sf1-eGFP litters (11.5-14.5 dpc) were dissected in cold PBS and gonads sexed by eye, based on the presence of testis cords (12.5-14.5 dpc) or by presence of Barr bodies (11.5 dpc; [19] ). For 11.5-dpc samples the mesonephros was left attached, but it was removed for 12.5-14.5-dpc samples. It should be noted that GFP-transgene expression is restricted to the somatic cells of gonad, exclusive of the mesonephros ( [12] ; this study). As only GFPpositive cells were profiled at 11.5 dpc, there was no mesonephric contamination. Stage-matched CD1 gonads, with mesonephros removed, were used as a negative control to determine GFP-positive populations.
Gonads were enzymatically dissociated using 0.25% Trypsin EDTA (Gibco) or TryplE Express (12604-013; Gibco) with 5 U/ml DNase1 (Sigma) for 20 min at 378C and then mechanically dissociated using 18-and 23-gauge syringes. PBS (1 ml) was added to the cells that were then pelleted by centrifugation (900 3 g at 48C for 10 min); after supernatant was removed the cells were resuspended in 400 ll of ice-cold PBS and stored on ice. Cells were then incubated with anti-SSEA1-PE (#FAB2155P; R&D Systems; specific for germ cells, fucosyltransferase 4 [FUT4]) or anti-CD31-APC (#551262; Becton Dickinson; specific for germ and endothelial cells, platelet/endothelial cell adhesion molecule 1 [PECAM1]) antibody for 20 min and washed with icecold PBS. Cells were resuspended in 400 ll PBS for sorting. Anti-SSEA1-PE was used in characterization of cell population studies and anti-CD31-APC was used to remove germ and endothelial cells prior to RNA-seq. Cells were fractionated using a BD FACSAria Cell Sorter; Supplemental Figure S1 shows FACS plots illustrating how gating parameters were derived. Specifically, GFPnegative CD1 stage-matched controls (Supplemental Fig. S1 , A and B) and GFP-positive but antibody-negative controls (Supplemental Fig. S1C ) were used to place gates for sorting GFP-high, GFP-low, GFP-neg, and antibodysorted (SSEA1-PE or CD31-APC) populations (Supplemental Fig. S1D ). These populations were collected in PBS and kept on ice before further processing.
Quantitative RT-PCR Analysis
Total RNA was extracted (Micro RNeasy kit with carrier RNA; Qiagen) and cDNA generated (High Capacity cDNA Reverse Transcription Kit; Invitrogen) from isolated populations of FACS-sorted cells as previously described [20] . Duplicate assays were conducted on an ABI Prism 7500 Sequence Detector System. The cycle conditions for quantitative RT-PCR (qRT-PCR) were 2 min at 508C, then 10 min at 958C, followed by 40 cycles of 928C for 15 sec then 608C for 60 sec.
Expression levels of mRNA were normalized to Tbp (TATA box binding protein; [21] ) and relative transcript abundance was determined using the 2 ÀDCT method. Tbp was used as a normalizing gene on the assumption that there were equal amounts of Tbp in each cell population as in the whole gonad [21] . For Taqman Gene Expression Assay reference numbers, see Supplemental Table  S3 . SEM was calculated from independent biological replicates (n ! 3) and statistical significance was determined using one-way ANOVA with Bonferroni multiple comparisons test to compare the four sample groups, with the exception of populations sorted at 11.5 dpc, where only two groups were compared and so statistical significance was determined using unpaired (twotailed) Student t-test.
RNA Extraction and Library Preparation for Deep Sequencing
Total RNA was extracted (Micro RNeasy kit without carrier RNA; Qiagen) from CD31-treated FACS-sorted cells. Each sample represented approximately 10 sorting experiments conducted on different days with 4-10 litters of Sf1-eGFP embryos in each experiment. We prepared, for each of 3 cell types (high-GFP, low-GFP, GFP-negative with GC/EC removed), replicate A, replicate B, and replicate C (C was an equal mix of samples A and B), resulting in nine samples for sequencing. A cDNA library was prepared from each sample using TruSeq Stranded Total RNA Libraries (RS-122-2201, Truseq stranded Total RNA LT [with Ribo-Zero Human/Mouse/Rat], Set A; Illumina protocol 15031048 Rev C, September 2012). The nine samples were run on four lanes of an Illumina HiSeq 1500, with all samples run over all lanes, generating 100-bp paired end reads after ribosomal depletion. Sequencing and library preparation were completed by the Monash Health Translation Precinct Medical Genomics Facility, Australia. Data have been submitted to GEO, accession GSE65498.
RNA-Seq Analysis
An average of 65 million raw reads were generated per sample. The quality of the sequencing files was examined using the FastQC program (FastQC; www.bioinformatics.babraham.ac.uk/projects/). Tophat2 [22] was used to map reads to the mouse genome (mm10), with mouse gene model annotations (mm10, downloaded from Ensembl [http://www.ensembl.org/info/data/ftp/ index.html]) supplied via the -G option. On average over 85% of the reads mapped to the mouse genome. Read counts were then summarized across genes using HTSeq-count [23] , with Ensembl mm10 gene annotation. No lane-MCCLELLAND ET AL. specific technical effects were observed; therefore, all lane files per sample were merged into one file per sample for differential gene expression analysis.
Differential Gene Expression Analysis
The count data were analyzed within the R statistical computing environment. Only genes with at least one count per million (cpm) in three or more samples were retained for further analysis. This reduced the number of features to 14 307 for the differential gene expression analysis (complete data in Supplemental Data S1). The count data of reads per gene feature were analyzed using TMM [24] and voom [25] for normalization and limma [26] for differential expression analysis, which applies empirical Bayes methods to compute moderated t-tests and P values adjusted for multiple testing using the Benjamini-Hochberg method [27] . Lists of the differentially expressed genes between each pair (contrast) of the three cell types were generated and annotated based on Ensembl mm10 annotation. Genes that were upregulated in one cell type compared to the other two cell types (adjusted P value ,0.05 and log fold change of at least 1 or 0.6 for each contrast) formed the upregulated gene lists for each of the cell types. The adjusted P value of the moderated F statistic (F), which combines the t statistics for all the contrasts into an overall test of significance for each gene, was used to rank the cell-specific gene lists for discussion. The full gene lists for all comparisons are in Supplemental Data S2.
To validate the RNA-seq data, we used the normalized sequence cpm to indicate expression of various marker genes (Supplemental Data S1). SEM was calculated from the three sequencing replicates and statistical significance was determined using one-way ANOVA with Bonferroni multiple comparisons test.
Previously Reported Genes
Genes that have testicular expression previously reported as having expression in the testis in articles on PubMed are listed in Supplemental Data S3.
Eurexpress Database In Situ Hybridization Mining
We searched the 14.5-dpc dataset from Eurexpress Transcriptome Atlas Database for Mouse Embryo (http://www.eurexpress.org) for in situ hybridization (ISH) data that might verify testicular expression for genes of interest identified in our RNA-seq analysis. Representative section images were downloaded and the testis region selected in Photoshop. Gene IDs and Eurexpress IDs are listed in Supplemental Table S4 .
Gene Ontology Analysis
Gene ontology (GO) analysis was performed using the DAVID Bioinformatics Package (v6.7) (http://david.abcc.ncifcrf.gov; [28, 29] ). The following three GO terms were used to categorize each population:
Transmembrane factor: SP_PIR_KEYWORDS transmembrane (GO:0016021; TM) Secreted factor: SP_PIR_KEYWORDS secreted (GO:0005576; SF) Transcription factor: GOTERM_MF_FAT transcription factor activity (GO:0003700; TF) For details of additional GO terms used, see Supplemental Data S4 and Supplemental Tables S5 and S6. The genes identified in each GO term category were then mapped back to the differentially expressed gene lists and ranked by F statistic.
Genes Putatively Regulated by NR5A1
The list of genes putatively regulated by NR5A1 is from Baba et al. [30] . The full list of overlapping genes is in Supplemental Data S5.
11.5-dpc Expression of FLC Genes
From our list of genes preferentially expressed in Leydig cells at 12.5 dpc, we sought to determine if any might potentially also mark Leydig cells at 11.5 dpc. To do this, we considered the data available for these genes at 11.5 dpc [15] . Genes found to be enriched in Leydig cells at 12.5 dpc that also show differing expression between the interstitial and supporting cell compartments of 11.5-dpc testes are putative pre-FLC marker genes. Data were obtained from GEO (GSE27715) and analyzed with R and Bioconductor. Raw data were normalized using oligo [31] and differential expression analysis was carried out with limma [26] . Int. Exp (interstitial) and Sup. Exp (supporting) show median normalized expression of the gene in each of these two cell types, and Int. Rank (interstitial) and Sup. Rank (supporting) indicate the position of the gene in a list ranked by expression in that cell type (0 ¼ lowest expression, 100 ¼ highest expression; Supplemental Data S6). For our final list of genes of interest we noted those genes with expression in interstitial cells more than four times that in supporting cells (log fold change ! 2). Of particular interest in predicting putative markers for FLCs are the 10 genes with low expression in supporting cells (Sup. Exp 6; marked in gray in Supplemental Table S7 ).
Genes Identified in Online Mendelian Inheritance in Man Database
A full list of genes associated with human disease from the Online Mendelian Inheritance in Man (OMIM) database (accessed 12 November 2014; http://omim.org/) is shown in Supplemental Data S7.
RESULTS
Evaluation of GFP as a Proxy for NR5A1/SF1 Expression in
Sf1-eGFP Mouse Fetal Testes
We previously used a 674-bp fragment of the Sf1/Nr5a1 (steroidogenic factor 1/nuclear receptor subfamily 5, group A, member 1) promoter to drive GFP expression in a subpopulation of somatic cells of the developing gonad in Sf1-eGFP transgenic mice (throughout this study we will refer to the this mouse line using the common name SF1/Sf1-eGFP) [12] . In that study, we profiled gene expression in the GFP-positive cell population at 10.5 and 11.5 dpc with the aim of identifying genes expressed in the Sertoli/granulosa cell lineage that may play a role in male or female sex determination. In the present study, we exploited a published observation that the NR5A1-positive cell population of the early male gonad can be subdivided into a high-NR5A1-expressing population that differentiates into pre-Sertoli cells and a low-NR5A1-expressing population that differentiates into a subset of the interstitial cells (presumptive FLCs) between 11.25 and 11.75 dpc [32] . Specifically, we sought to determine whether FLCs could be isolated from fetal testes based on GFP expression level in Sf1-eGFP transgenic mice. We reasoned that this strategy might allow molecular characterization of the FLC lineage at 12.5 dpc, a time point that would allow identification of genes involved in FLC specification prior to large-scale upregulation of steroidogenesis genes.
In our previous study we established colocalization of NR5A1 and GFP at 11.5 dpc and we confirmed this here (Supplemental Fig. S2, A , B, and G; [12] ). We showed that NR5A1/GFP-positive cells were SOX9 positive and ARX/ DDX4 negative at 11.5 dpc (DEAD box polypeptide 4; MVH; Supplemental Fig. S2, A , B, and G). We then demonstrated that endogenous expression profile of NR5A1 was mirrored by GFP expression in XY gonads at 12.5 dpc. Immunofluorescence analysis showed that cells with nuclear NR5A1 expression showed cytoplasmic expression of the GFP transgene ( Fig. 1 , first column). As this analysis was performed using single confocal slices on sectioned embryos, not all cells in an image would be expected to have both nuclear and cytoplasmic staining. We then used lineage-specific marker antibodies to determine which cell types expressed GFP/ NR5A1 in our transgenic line. GFP/NR5A1-positive cells lined the testis cords and NR5A1-positive nuclei in ''strongly'' GFPpositive cells colocalized with nuclear SOX9 at 12.5 dpc and later, indicating that the transgene was expressed in Sertoli cells ( Fig. 1A; Supplemental Fig. S2 , B, D, and F). We deduced that interstitial ''weakly'' GFP-positive cells were presteroidogenic FLCs by virtue of their nuclear expression of NR5A1 (Fig. 1 , A-C, first column; [33, 34] ). This was confirmed by immunofluorescence for ARX, a nuclear marker CHARACTERIZING THE FETAL LEYDIG CELL TRANSCRIPTOME of non-FLC interstitial cells at 12.5 dpc: ARX did not colocalize with the NR5A1-positive nuclei of GFP-positive interstitial cells (Fig. 1B) . Additional analysis at 13.5-14.5 dpc showed that GFP/NR5A1-positive cells in the interstitium that were exclusive of ARX-positive nuclei expressed cytoplasmic HSD3b, confirming that FLCs expressed the GFP transgene (Supplemental Fig. S2 , C, E, H, and J). We also confirmed that the transgene was not expressed in germ cells: GFP/NR5A1-positive cells were negative for germ cell marker DDX4 ( Fig.  1C; Supplemental Fig. S2 , G, I, and K). These results demonstrate that GFP, like endogenous NR5A1, is expressed in the Sertoli cell and FLC populations in Sf1-eGFP transgenic testes at 12.5 dpc and beyond.
Isolation and Characterization of Fetal Testis Cell Populations
The above observations suggested that it might be possible to separate three populations of somatic cells from 12.5 dpc Sf1-eGFP transgenic testes based on GFP fluorescence: strongly GFP-positive (''high-GFP'') Sertoli cells, weakly GFP-positive (''low-GFP'') FLCs, and a GFP-negative population of NSICs. In addition, a fourth cell population, the germ cells, could be isolated using well-characterized antibodies to cell surface markers. To this end, we explanted and dissociated Sf1-eGFP testes, incubated the cells with antibodies to either SSEA-1 (recognizing germ cells only) or CD31 (recognizing germ and endothelial cells), and used FACS to separate the four cell populations ( Fig. 2A) .
We profiled expression of key marker genes by qRT-PCR in the four populations of cells to investigate their composition. As expected, the high-GFP population (Fig. 2 , dark green) robustly expressed Sertoli cell hallmarks including Nr5a1, Sox9, Amh (anti-Müllerian hormone), and Ptgds (prostaglandin D2 synthase; Fig. 2 , B-E). These cells expressed low levels of Leydig cell markers Star (steroidogenic acute regulatory protein) and Cyp11a1 (cytochrome P450, family 11, subfamily a, polypeptide 1; Fig. 2, F and G) . This pattern of marker expression was established at 11.5 dpc (Supplemental Fig. S3 , A and B) and retained until at least 14.5 dpc (Fig. 2 , J-L; Supplemental Fig. S3, C-E and H-M). Therefore, we concluded that the high-GFP-expressing population is enriched for Sertoli cells. Surprisingly, Ptch1 was expressed at similar levels in the high-GFP (putative Sertoli) and low-GFP (putative FLC) populations (Fig. 2H) : despite reports that Ptch1 expression is characteristic of FLCs [6, 35] , high-quality expression data agree with our findings and indicate that Ptch1 is expressed at similar levels in Sertoli and testicular interstitial cell populations at 12.5 dpc ( [16] ; this study).
The low-GFP-expressing population (Fig. 2 , light green) was characterized by reduced expression of Nr5a1 at 12.5 dpc and weak expression of Sox9, Amh, and Ptgds (Fig. 2, B-E) . At this stage of testis development, expression of steroidogenic genes begins at a low level in the FLCs. Accordingly, expression of early FLC marker Star was similar between GFP-positive populations; however, elevated levels of early steroidogenic pathway member Cyp11a1 were detected in the low-GFP population (Fig. 2, F and G) . These and other steroidogenic markers became more highly expressed in the low-GFP population at 13.5 and 14.5 dpc ( Fig. 2L ; Supplemental Fig. S3 , D, E, and K-M). Therefore, we conclude that the low-GFP expressing population is enriched for FLCs at 12.5 dpc.
FIG. 2. The high-GFP population represents Sertoli cells and the low-GFP population represents FLCs in 12.
5-dpc XY Sf1-eGFP gonads. A) Schematic of FACS protocol for the XY Sf1-eGFP gonads; four cell populations were isolated by FACS using a germ (GC)-or germ cell/endothelial cell (GC/EC)-depleted sorting method. B-I) At 12.5 dpc, qRT-PCR for somatic marker Nr5a1 (B) and Sertoli cell markers, Sox9 (C), Amh (D), and Ptgds (E) showed that the high-GFP-expressing cell population was enriched for Sertoli cells. The low-GFP expressing cell population expressed low levels of Sertoli cell markers. Early FLC marker Star (F) was similar in the two GFP-positive populations; however, Cyp11a1 (G) was elevated in the low-GFP population. Interstitial markers Ptch1 (H) and Arx (I) are the only markers expressed in the GFP-negative population. The same trend was observed at 13.5 dpc: high-GFP expressing cells expressed Nr5a1 (J) and high levels of Sox9 (K), whereas low-GFP expressing cells were confirmed to be enriched for FLCs, as they expressed high levels of Cyp11a1 (L). For all qRT-PCR: levels are shown relative to Tbp; error ¼ SEM; *P ¼ 0.05, **P ¼ 0.001, ***P ¼ 0.0001, ****P ¼ 0.00001, ns ¼ not statistically significant. [35] and Jameson et al. [15] datasets is represented; only six genes are present in all three datasets. See Table 1 for lists of genes in each category. B-O) The qRT-PCR for candidate genes identified as being differentially expressed between cell types on sorted cell populations from the 12.5-14.5-dpc Sf1-eGFP XY gonad. Novel genes identified as being highly expressed in enriched FLC:
, and Adcy7 (I). Novel genes highly expressed in enriched NSICs: Frem2 (J), Fras1 (K), and
The germ cell-depleted, GFP-negative, putative NSIC population (Fig. 2, gray) showed minimal expression of Nr5a1; Sertoli cell markers Amh, Ptgds, and Dhh; and FLC markers Star, Cyp11a1, and Hsd3b (hydroxy-delta-5-steroid dehydrogenase, 3 beta-and steroid delta-isomerase 1), indicating that it was devoid of Sertoli cells and FLCs (Fig.  2 
, B-G and J-L; Supplemental Fig. S3, C-E and H-M).
Among the genes we examined, only the DHH receptor Ptch1 (patched homolog 1) and Arx were expressed in the GFPnegative population (Fig. 2, H and I; Supplemental Fig. S3, F-H, N, and O) . These data indicated that the germ cell-depleted, GFP-negative population was enriched for NSICs that did not express NR5A1/Nr5a1 or any other Sertoli or FLC markers.
Although germ cells were not the focus of this analysis, we also examined the expression of Ddx4 to examine the efficiency of germ cell depletion from the GFP-negative fraction. As expected, expression of Ddx4 was robust in this cell population from 12.5 to 14.5 dpc (Supplemental Fig. S3 , P-R), but some expression was also in the GFP-negative fraction at 12.5 dpc (Supplemental Fig. S3P) , indicating a low level of germ cell contamination.
To validate the purity of the high-GFP and low-GFP cell populations using the high-GFP/low-GFP FACS separation strategy described above, we performed immunofluorescence on FACS-sorted cell populations for NR5A1, Sertoli cell marker SOX9, germ cell marker DDX4, and vascular endothelial cell marker iB4 (isolectin B4; Supplemental Fig.  S1 , E-G). We found that virtually all cells in both the high-GFP and low-GFP populations were NR5A1 positive, as expected, whereas the GFP-negative population was devoid of NR5A1-positive cells (Supplemental Fig. S1E) . Results of this analysis were consistent with those obtained by qRT-PCR and indicate that virtually all cells in the high-GFP population (putative Sertoli cells) were SOX9-positive; therefore, this population was a relatively pure population of Sertoli cells ( Fig. 2C; Supplemental Fig. S1F ). On the other hand, about 7.6% of cells isolated in the low-GFP population (putative FLCs) were SOX9-positive, indicating that a low level of Sertoli cell contamination was present in the FLC population ( Fig. 2G; Supplemental Fig. S1F ). Although our strategy attempted to remove the majority of germ and endothelial cells using a CD31 antibody, we found that about 22% of cells in the GFP-negative fraction were DDX4-positive germ cells and that approximately 6.4% of the GFP-negative population of cells were iB4-positive endothelial cells ( Fig. 2A; Supplemental Fig.  S1G ). We also tested for staining of Leydig cell markers CYP11A1 and HSD3b, but, as in section immunofluorescence, these markers proved uninformative at 12.5 dpc. These data indicated that the population purity of the three FACS isolated somatic cell populations was sufficient to represent the different enriched fetal testis cell populations.
Generation and Quality of RNA-Seq Data
We next analyzed the transcriptomes of the sorted testicular cell populations by RNA-seq. Cells were collected from 12.5-dpc Sf1-eGFP XY gonads, depleted of germ and endothelial cells using a CD31 antibody, and fractionated into three populations using the methods described above (Fig. 2A) . Triplicate samples of each somatic cell population were generated, RNA was isolated and reverse transcribed, and the resulting cDNA deep sequenced using a paired-end 100-bp stranded sequencing format on Illumina HiSeq 1500. An average of 65 million raw reads were generated per sample. Supplemental Data S1 provide a spreadsheet of cpm RNA-seq data for all Ensembl gene IDs detected at .1 cpm in 3 or more samples (data can be accessed from GEO; GSE65498).
To validate the RNA-seq data, we examined the normalized sequence cpm as an indicator of expression of various marker genes (Supplemental Fig. S4, A-I ; Supplemental Data S1). The results of this analysis were consistent with results obtained by qRT-PCR, with the exception of Star, where transcripts were detected in the NSIC population at low levels in the RNA-seq data (Fig. 2, B-I; Supplemental Fig. S4, A-I ). These data indicated that the RNA-seq output accurately represented the transcriptomes of the different enriched fetal testis cell populations.
Differentially Expressed Gene Analysis
Genes were identified as being upregulated in a cell population if they showed .1 log fold change and adjusted P value ,0.05 in the differential expression analysis compared to either of the other cell types. As expected, the GFP-negative fraction isolated by FACS was negative for Sertoli and FLC markers. However, each of the GFP-positive populations contained some transcripts characteristic of other populations, consistent with results obtained by qRT-PCR (Fig. 2 , B-L; Supplemental Figs. S3 and S4). That is, some FLCs were likely to have contaminated the Sertoli cell-enriched fraction (Fig.  2G , low-level expression of Cyp11a1) and some Sertoli cells were likely to have been present in the FLC-enriched fraction (Fig. 2C , low-level expression of Sox9). For this reason, the log fold cutoff off was lowered to .0.6 for these samples, to reduce the potential of obtaining false negatives when compiling lists of cell type-specific genes. In this way, we identified a group of genes upregulated in each enriched cell population: 84 FLC-enriched genes, 704 NSIC-enriched genes, and 1217 Sertoli cell-enriched genes (Supplemental Data S2). Validation of a subset of the genes from the lists of upregulated transcripts demonstrates that a gene in these lists is likely to be expressed in a single testicular cell population at 12.5 dpc.
Validation of the FLC-Enriched Gene Dataset
As a first step in validating the 84 candidate FLC genes, we compared them to results of published studies. Of these genes, 72% (61 genes) were previously unreported in the two published microarray datasets that have provided lists of candidate FLC genes at 12.5 dpc ( [15, 35] ; Fig. 3A ; Table 1) . A number of genes had been identified as being expressed in whole adult testis, although for most no further gonadal or fetal gonadal characterization has been performed (Supplemental Data S3). Four of the 84 genes (Htra3, Vcam1, Bmp2, and Kcnk3) overlapped with a list of 567 genes identified as putatively regulated by NR5A1 by performing RNA-seq on Y-1 cells treated with Nr5a1-siRNA [30] consistent with Nr5a1's pivotal role in FLC specification and differentiation.
We next analyzed temporal and cell-specific gene expression of candidate FLC genes by qRT-PCR on sorted Sf1-eGFP cell populations at 12.5-14.5 dpc. These analyses confirmed FLC-enriched expression of Tacr3, Tac2, Prlr, Sox18, Mc2r, 5 dpc, n ¼ 3, 3, 3, 3, 14.5 dpc, n ¼ 3, 4, 4, 3) . For all qRT-PCR, levels are shown relative to Tbp; error ¼ SEM.
CHARACTERIZING THE FETAL LEYDIG CELL TRANSCRIPTOME and Adcy7 compared to NSICs (Fig. 3, B, C, E-G, and I). Prlr was expressed in the FLC population with expression increasing from 12.5 dpc (Fig. 3E ). Robo2 and Clca1 appeared to be expressed equally in FLCs and NSICs by qRT-PCR (Fig.  3, D and H) . Expression of Tacr3 was elevated in the FLCenriched population at 12.5 dpc and was subsequently expressed in the FLC and NSIC populations (Fig. 3B) . Interestingly, Tac2, Sox18, and Adcy7 were expressed more highly in the FLC than in the NSIC population at 12.5 dpc only before becoming either expressed in multiple populations or downregulated (Fig. 3, C, F, and I) .
Lastly, we examined the ISH staining patterns of the FLC genes identified by RNA-seq at 14.5 dpc, when FLCs have upregulated steroid production, using the Eurexpress whole embryo section ISH database [36] . Of the eight expression profiles analyzed in this way (Adcy7, Clca1, Itga9, Nrg1, Nts, Prlr, Srpx2, and Tacr3), all showed the expected expression in the interstitial space, similar to the known FLC marker Cyp11a1 (Fig. 4, A and D-K) , and distinct from the cordassociated expression of the Sertoli cell marker Amh (Fig. 4C) . Taken together, these validation steps confirmed that the putative FLC gene dataset generated in this study represents an accurate subset of the FLC transcriptome.
Mining of the FLC-Enriched Gene Dataset
We sought to generate a transcriptional portrait of the FLCs based on the RNA-sequencing dataset. We performed GO analysis, using the DAVID Bioinformatics Package, for each of the three outputs of the differentially expressed gene analysis. Fig. 3A ).
FLC genes found in Gene lists
This study, Jameson et al. [15] , and McDowell et al. [35] Inhba, Ppp1r14a, Prlr, Prokr2, Robo2, Vsnl1 This study and Jameson et al. [15] C7, Casq2, Cbln1, Grin2a, Hhip, Hspa12a, Itga9, Kcnj3, Mc2r, Nts, Stc1, Vcam1 This study and McDowell et al. [35] Crhr1, Htra3, Itih5, Srpx2, Vgll3 Jameson et al. [15] and McDowell et al. [35] Aebp1, AI427809, Cyp11a1, Cyp17a1, Fads1, Gramd1b, Hsd3b1, Lhcgr, Npy, Star This study only Adamts5, Adcy7, Arhgap6, Armcx6, Art3, Bmp2, Btnl9, Chst1, Chst2, Clca1, Clec1b, Col23a1, Cyp1b1, Ffar2, Gja5, Gm11549, Gm13659, Gm14396, Gm5067, Gpr153, Gpr174, Gpr20, Grrp1, Hoxd10, Hoxd11, Hsd11b2, Irf8, Itga4, Kcnk3, Kcns2, Lars2, Lrrtm3, Mc4r, Mme, Mmp28, Myh11, Myh7, Myl4, Myoc, Ngfr, Nrg1, Oit3, Otof, Pcp4l1, Pdyn, Plcxd3, Pnmal1, Ptpro, Rad51ap2, Serpina3g, Sertm1, Slitrk2, Sox18, Speer7-ps1, Sstr4, Syt15, Tac2, Tacr3, Tg, Trac, Vipr1 Jameson only [15] A430107O13Rik, Ace2, Adam12, Alas1, Armcx2, Atp1a3, Clca2, Col6a1, Copz2, Cxcr7, Cyp51, Enpep, Ephx1, Fat3, Fdps, Fdx1, Gpc3, Gpm6a, Grk5, Hsd17b7, Jag1, Mobkl3, Osr2, Pltp, Prkar2b, Pros1, Rbp4, Ren1, Sc4mol, Scarb1, Sct, Slc6a15, Smoc2, Ssfa2, Tgfbr3, Tnc, Tpm2, Trib2, Zeb2 McDowell only [35] 1200009O22Rik, 4930474M22Rik, 5031410I06Rik, Abcc9, Adamts7, Alcam, Arx, B3galt1, Cd36, Cdkn2c, Dlc1, Fbn1, Glipr2, Gpx3, Gria4, Gsta2, Gucy1b3, Inha, Insl3, Itgb8, Itm2a, Lrrk2, Ltbp4, Ng23, Nuak1, Pi15, Ptrf, Scd1, Sec24d, Slc29a1, Speer4d, Thbd, Tm7sf2
List of FLC genes identified in this study, the McDowell et al. dataset [35] , and the Jameson et al. dataset [15] at 12.5 dpc indicating unique and overlapping genes between datasets.
CHARACTERIZING THE FETAL LEYDIG CELL TRANSCRIPTOME Ten of the identified genes for each of three ontologies (transmembrane factors, secreted factors, and transcription factors) for each sorted cell population are listed in Fig. 5 . Among the 84 candidate FLC genes, we identified 35 genes encoding transmembrane components (P ¼ 2.33EÀ03); of these, there was an overrepresentation of genes involved in neurogenesis/neurotransmission (Supplemental Table S5 ), with eight encoding receptors, or receptor components, for neuroactive ligands (Tacr3, Mc4r, Prlr, Crhr1, Mc2r, Sstr4, Grin2a, and Vipr1; P ¼ 2.96EÀ03). Additionally, five receptors were identified as being involved in cell adhesion (Robo2, Itga4, Itga9, Vcam1, and Arhgap6; P ¼ 9.86Eþ01). Secreted factors were also overrepresented, with 14 secreted factors upregulated in the enriched FLC population including, Tac2, Hhip, Pdyn, and Inhba (P ¼ 9.98EÀ02). Finally, we identified four genes encoding transcription factors in the FLC enriched population: Hoxd10, Hoxd11, Irf8, and Sox18 (P ¼ 1.00Eþ02). We queried the OMIM Database and found that 30 of the candidate FLC genes are associated with human disease phenotypes (26 where the molecular basis is known; eight listed in Table 2 ; full list in Supplemental Data S7). Analysis of published literature revealed that genetic deletion of some of a Chr., chromosome. b Phenotype indicates the embryonic or postnatal phenotype of the null animal. Information from published reports where there was postnatal survival mutations were classified as ''no lethal developmental defects'' (indicates that the null offspring were obtained as adults at the expected Mendelian ratios) or ''fertile'' (indicates that the mice were able to reproduce normally). FSH, follicle-stimulating hormone. c OMIM assoc. ¼ OMIM reference number if the gene is associated with any type of human disorder (* indicates a genitourinary, endocrine, or DSD phenotype). d References are the primary report of the null or mutant mouse and any subsequent clarifying reports.
the genes upregulated in the FLC-enriched population results in embryonic lethality (Table 2 ) from a variety of causes, including cardiac (Nrg1 [37] ), respiratory (Hhip [38] ), and vascular defects (Ngfr [39] ). Among these, gene knockout of Robo2, Prokr2, and Tacr3 in mice resulted in defects in postnatal urogenital and reproductive system development [40] [41] [42] . Interestingly, these three genes encode transmembrane receptors important for neuroactive-ligand signaling. Finally, we sought to determine if any FLC genes at 12.5 dpc might also mark pre-FLCs at 11.5 dpc and might therefore be useful in clarifying the developmental origin of FLCs. We reanalyzed a previously published microarray dataset [15] and considered whether genes we found to be enriched in FLCs at 12.5 dpc were also robustly upregulated in the ''interstitial'' population (which includes pre-FLCs) compared with the ''supporting'' (pre-Sertoli) population at 11.5 dpc: we reasoned that such genes may mark FLCs even before they attain steroidogenic capacity. This analysis resulted in the identification of 10 genes of interest: Prokr2, Itga9, Ptpro, Ngfr, Clca1, Adamts5, Nrg1, Arhgap6, Myl4, and Hsd11b2 (Supplemental Table S7 and Supplemental Data S6). These genes, characterizing non-Sertoli NR5A1-positive cells prior to FLC maturation (which occurs between 12.5 and 13.5 dpc), may act as early markers for the FLC lineage and, therefore, may aid our understanding of FLC specification and differentiation.
NSICs Versus FLC Transcriptomes: Clues to the Origin of FLCs
It is clear that signaling from Sertoli cells to interstitial cells plays a critical role in the specification of FLCs [4] . Early expression of NR5A1 in pre-FLCs precedes steroidogenesis and is likely important for their future steroidogenic capacity. However, it is not clear why only some interstitial cells respond to signals such as DHH by initiating steroidogenesis; this is especially puzzling because non-FLCs of the interstitium are apparently capable of responding to DHH as they express the receptor PTCH1 [6] . Here we confirm that NSICs express PTCH1 (Fig. 2H and Supplemental Fig. S3, F and N) : previous studies have demonstrated that PTCH1, along with receptors for other Sertoli-produced factors such as PDGFa, are expressed in a pan-interstitial manner [9] . We reasoned that knowledge of early markers that do discriminate NSICs from FLCs may help explain why only FLCs differentiate in response to Sertoli-derived cues.
NSICs that express NR2F2 at 18.5 dpc are considered progenitor cells for the ALC population [2] , but it is not known whether these cells also express NR5A1 [43] . To help clarify this issue, we examined whether NR2F2-positive cells in the fetal testis were also positive for NR5A1. At 11.5 dpc most NR2F2-positive cells also expressed ARX, a smaller proportion expressed NR5A1, and some triple-positive cells were seen (Supplemental Fig. S5A ). From 12.5 to 14.5 dpc, NR2F2 cells were ARX positive but negative for NR5A1 (Supplemental Fig. S5 , B-D) with few exceptions (gray arrow, Supplemental Fig. S5, B-D) . Unless NR2F2 cells begin to express NR5A1 at later time points, these data would suggest that ALC progenitors do not express NR5A1 during fetal life.
We looked at the heterogeneity of the isolated NSIC population by performing DAVID analysis on the upregulated genes (704 genes). We established that the NSIC population contained both blood cells and macrophages, which have been shown to be important for testis morphogenesis and vascularization [44] . We identified a subset of genes involved in hematopoiesis (29 genes; P ¼ 1.26EÀ04), leukocyte activation (24;
Subsequently, we performed qRT-PCR on sorted Sf1-eGFP cell populations to verify the NSIC-enriched expression of genes upregulated in the NSIC list. We detected expression of Car2 in NSICs but not FLCs by qRT-PCR (Fig. 3L) , whereas expression of Car2, Slc6a18, and Ermap by ISH was consistent with the predicted interstitial expression pattern for the candidate genes (Fig. 4, B and L-N) and distinct from the cord-associated expression of the Sertoli cell marker Amh (Fig.  4C) . Therefore, at least Car2 appears to be a novel marker for NSICs that warrants further investigation.
Next, we looked to identify additional factors that set NSICs apart from FLCs. We observed an overrepresentation of genes associated with developmental processes (Supplemental Table  S6 ) in the NSIC-enriched population. Interestingly, the NSIC population was marked by expression of transcription factors, including Hoxd3, Hoxb2, Olig1, and Gata5 (57 genes; P ¼ 1.49EÀ05; Supplemental Table S6 ), suggesting that this population is involved in active developmental processes at this critical stage of gonadal development; we found very few transcription factors characteristic of the FLC population. In addition, GO analysis identified numerous transmembrane component genes not expressed in the FLC population that may be involved in Sertoli-NSIC cell signaling (including Frem2, Prokr1, Ntrk2, Cdh16, and Adam22; 177 genes; P ¼ 2.22EÀ04; Supplemental Table S6 and Fig. 5 ). Two hundred three of the genes identified as being upregulated in the NSICenriched population have been associated with a phenotype in OMIM, and for 162 of these the molecular basis is known (eight listed in Table 3 ; full list in Supplemental Data S7).
One of the transmembrane components identified in NSICs but not FLCs was Frem2/FREM2 (Fras1-related extracellular matrix protein 2), a cell surface receptor that is a known DSD gene causing Fraser syndrome (OMIM: 219000; Table 3 ; [45] ). Expression of Frem2 has not been reported previously in the fetal gonad. By qRT-PCR we established that Frem2 and its close family member Fras1 (Fraser syndrome 1 homolog), which is also involved in Fraser syndrome, are expressed in the NSIC-enriched population of the testis at 12.5-13.5 dpc (Fig.  3, J and K) . These data established that there is a large group of factors, some of which are known to be relevant to human DSD, which set NSICs apart from FLCs during early development. These genes may be relevant to the fate decisions made by NSICs at the time of FLC specification.
Sertoli Cells: Signaling to the FLCs and NSICs
Understanding of the process of interstitial cell specification requires knowledge of all potential paracrine factors produced by newly specified Sertoli cells. In addition to published microarray data from enriched Sertoli cells, we used RNA-seq to survey the Sertoli cells in greater detail [15] . Our RNA-seq analysis identified 1217 genes upregulated in the Sertoli cellenriched population (Supplemental Data S2), and these included a number of previously described fetal Sertoli cell genes (Aard, Dhh, Mro, Ptk2b, Cst9, Col9a3, Aldh1a1, and Amh), thereby validating our approach. We identified Trank1, Gstm7, and Adamts16 as novel genes expressed in the Sertoli cell population by qRT-PCR and ISH (Fig. 3, M-O, and Fig. 4 , C and O-Q). DAVID analysis identified genes that encoded transmembrane factors (330 genes; P ¼ 3.19EÀ10), and 44 genes with transcription factor activity (P ¼ 6.7EÀ1) were upregulated in the Sertoli cell-enriched population (Fig. 5) .
Interestingly, as in the FLC-enriched population list, we found a number of gonadotropin-releasing hormone (GnRH)-CHARACTERIZING THE FETAL LEYDIG CELL TRANSCRIPTOME Fig. 4 ) including Dhh. We looked for known ligand pairs for the 35 FLC receptors identified in our RNA-seq data and the reprocessed Jameson et al. [15] data. We identified expression of the genes encoding known ligands to the neuroactive receptors (Mc2r, Mc4r, Crhr, Vipr1, Prlr, Sstr4, and Tacr3), a related receptor (Adcy7), and two neurogenesis-related receptors (Prokr2/Robo2) in our RNA-seq data and/or the reanalyzed Jameson dataset (Fig. 6) .
DISCUSSION
We used RNA-seq to define the transcriptome of FLCs and compare it to those of NSICs and Sertoli cells in mice at 12.5 dpc in order to identify novel early markers of individual cell types in the developing testis, with particular focus on the FLC population. We anticipated that a detailed portrait of the genes expressed in FLC just prior to the onset of steroidogenesis, in comparison to a similar picture of the Sertoli and NSIC transcriptomes, would prove informative in terms of understanding how FLCs come to be specified and how they differentiate to become functional hormone-producing cells. Although previous studies have profiled somatic cells early in gonadogenesis [15, 35] , the present study provides the first   FIG. 6 . Schematic of putative receptor-ligand interactions focusing on the receptors overexpressed on FLCs and NSICs. Receptors associated with neuroactive ligand signaling and/or DSD are represented. Ligands were identified from the literature and expression of ligands in cell types of the testis at 12.5 dpc was determined using data from this study and reprocessed Jameson et al. [15] data. The resulting schematic details proposed receptor-ligand interactions inferred from data at 12.5 dpc in the XY gonad. GJA5 shuttles glutamate, which is a ligand for the NMDA receptor of which GRIN2A is a subunit. The POMC complex is produced by Sertoli cells and its derivatives activate MC2R and MC4R. CRH is a ligand for CRHR1, whereas GHRH and ADCYAP1 (or PACAP) are ligands for VIPR1. ADCYAP1 can also activate ADCY7. PRL and SST are the ligands for PRLR and SSTR4 respectively and are expressed by vascular endothelial cells (VECs). TAC2 is predominately expressed by FLCs but also by Sertoli cells, whereas VECs and Sertoli cells express TAC4. Both TAC2 and TAC4 can activate TACR3. PROK1 and PROK2 can activate PROKR2. SLIT1/2/3 can activate ROBO2 and are expressed in the testis. The ligand GRIP1 is responsible for activating FREM2 and its close family member FRAS1. CHARACTERIZING THE FETAL LEYDIG CELL TRANSCRIPTOME RNA-seq analysis of enriched FLC, NSIC, and Sertoli cell populations in the XY gonad. The method we developed for separating cell types has yielded the purest and most validated population of pre-FLCs yet reported. Determining which cell types a given gene is expressed in has hitherto been typically a labor-intensive task [46, 47] . Aside from providing the basis for our transcriptomic analysis, the system we developed will be useful in future studies designed to assign expression of any novel gene to a particular cell lineage using qRT-PCR.
We found that 61 of the overexpressed genes in the FLCenriched population were previously unreported in the fetal gonad and therefore represent novel candidates for involvement in FLC specification. By checking previously published 11.5-dpc microarray data for genes we identified as FLCupregulated at 12.5 dpc, we identified 10 robustly expressed putative presteroidogenic FLC marker genes. One of these is Prokr2, which we have previously shown to be expressed in the XY 11.5-dpc genital ridge [46] , thereby validating this approach. Some of these 10 genes may prove useful in identifying pre-FLCs before they begin to express characteristic steroidogenic enzyme genes.
Hormones produced by the FLCs direct the masculinization of the embryo. Even though key components of the hypothalamic-pituitary-gonadal (HPG) axis are in place from around 16.5 dpc, the production of hormones by FLCs is thought to be independent of the HPG axis [48] [49] [50] [51] [52] . The GnRH-neural circuitry is a key component of the HPG; the formation and activation of the GnRH-neural circuitry involves a series of neuroactive ligand/receptor pairs; mutation of genes involved in this circuitry often results in DSD, which, it has been assumed, is primarily associated with HPG axis dysfunction [53] [54] [55] . Oddly, we found that a number of genes associated with these processes, which occur after the differentiation of FLCs, are expressed in the Sertoli cells and FLCs at 12.5 dpc. Of the 35 genes that encode receptors, in the FLC upregulated list, DAVID analysis identified 8 factors associated with neuroactive-ligand signaling (Mc2r, Mc4r, Grin2a, Crhr1, Vipr1, Prlr, Sstr4, and Tacr3; Fig. 6 ). In addition, we identified Adcy7, which encodes a receptor that is a regulator of intracellular cAMP concentration and that shares the ligand PACAP, encoded by the gene Adcyap1, with VIPR1 [56, 57] . Also of interest was the expression of Gja5, which encodes a gap junction protein CX40 involved in shuttling glutamate, an activator of the N-methyl-D-aspartate (NMDA) glutamate receptor, of which GRIN2A is a subunit (Fig. 6 ; [58] [59] [60] ). Furthermore, Robo2 and Prokr2 were of interest, as both are implicated in neuronal processes and GnRH signaling [41, [61] [62] [63] . Assessment of the known ligands for the 11 receptors of interest indicated that putative ligand pairs were expressed in the FLCs, Sertoli cells, or vascular endothelial cells ( Fig. 5 ; this study; [15] ). Whether the testicular expression of these genes plays a role in gonadogenesis is yet to be determined, but the observation that they dominate the subgroup of FLCupregulated genes that are not associated with steroidogenesis may be significant.
These findings also have implications for identifying the causes of DSD. Of the neuroactive genes identified, some that are upregulated in FLCs have previously been associated with DSDs that have urogenital phenotypes, for example PROKR2 and TACR3. Mutations in PROKR2 (OMIM: 244200; [64] ) and TACR3 (OMIM: 614840; [65, 66] ) are associated with hypogonadotrophic hypogonadism in humans and mice. As many of the factors associated with neuroactive-ligand receptor activation and other neuronal processes are expressed robustly in the FLCs or the Sertoli cells of the developing testis (this study; [21] ) it is tempting to speculate that gonadal production of these factors may precede HPG-driven production and explain male bias in individuals affected by hypogonadotrophic hypogonadism [46, 55, 64, 67] . Prokr2 À/À mice have reproductive defects, and we have previously shown that there was no change in expression of FLC marker HSD3b/Hsd3b in Prokr2 À/À embryos compared to wild-type littermates [41, 46] . However, embryonic Prokr2 À/À testes display vasculature dysmorphology, a phenotype often associated with FLC impairment [10, 46] . Tacr3 À/À mice have a variety of reproductive and fertility defects and a postnatal hormone profile similar to that of several other GnRH-deficient mouse models [41, 42, 68] . Our results suggest that more detailed analysis of the postnatal and embryonic gonadal phenotype of the Tacr3 À/À mouse is needed to assess the effect of TACR3 loss before HPG axis activation occurs.
We identified that Frem2 and Fras1, known DSD genes, are overexpressed in the NSIC population of the XY gonad from 12.5 to 13.5 dpc. Mutations in Frem2 and Fras1 result in Fraser syndrome (OMIM: 219000; [45, 69] ) a multisystem disorder with ambiguous genitalia in 20% of patients (for review see [70] ). Frem2 knockout mice also have multiple developmental defects; however, the ambiguous genitalia phenotype seen in patients has not been characterized in mouse [45] . We postulate that a requirement for expression of Frem2 and Fras1 in NSICs early in gonadogenesis may contribute to the ambiguous genitalia phenotype seen in this model. This finding supports the idea that NSICs, not just Sertoli and FLCs, may play an important role in masculinization during fetal life.
It has recently been shown that some non-FLC of the interstitium differentiate into ALCs postnatally [2] , establishing that a functional fetal NSIC population is important for postnatal masculinization of the individual. We find that early in gonadogenesis the NSIC population is characterized by expression of NR2F2 and a set of transcription factors and transmembrane receptors that are distinct from those of the FLC population. The differences we have identified between transcriptomic profiles in FLC-and NSIC-enriched populations may provide leads as to how pre-FLCs are selected or how NSICs resist selection from within the total interstitial population.
Functional investigation into individual genes shown to be upregulated in the various cell types, and processes highlighted as likely to be active within and between cells, will be needed if we are to gain a clearer understanding of gonadogenesis and postnatal sexual development, particularly as they relate to steroid production. We envisage that this dataset will be a resource to identify genes involved in normal gonadogenesis, in mouse and human, and to pinpoint genes likely to underlie some cases of human DSD.
